News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
138 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53927)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21901)
Month
January (3218)
February (3391)
March (3462)
April (3660)
May (4506)
June (2887)
July (2191)
August (2499)
September (2720)
October (3233)
November (3383)
December (2291)
Day
1 (138)
2 (86)
3 (59)
8 (97)
9 (101)
10 (84)
11 (105)
12 (56)
15 (90)
16 (125)
17 (106)
18 (118)
19 (57)
22 (108)
23 (101)
24 (100)
25 (139)
26 (75)
29 (161)
30 (126)
31 (159)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
8
9
10
11
12
15
16
17
18
19
22
23
24
25
26
29
30
31
Business
Merck to Hold Second-Quarter 2024 Sales and Earnings Conference Call July 30
Merck, known as MSD outside of the United States and Canada, will hold its second-quarter 2024 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Tuesday, July 30.
July 1, 2024
·
3 min read
Business
Cyrus Taraporevala Elected to Pfizer’s Board of Directors
Pfizer Inc. announced the election of Cyrus Taraporevala to its Board of Directors, effective immediately.
July 1, 2024
·
2 min read
Biotech Bay
NovaBay Pharmaceuticals and Eyenovia Commence Co-Promotion Activities
NovaBay® Pharmaceuticals, Inc. and Eyenovia, Inc. have commenced activities under a previously announced co-promotion agreement.
July 1, 2024
·
8 min read
Press Releases
Zenas BioPharma Appoints Orlando Oliveira as Chief Commercial Officer
Zenas BioPharma today announced the appointment of Orlando Oliveira as its Chief Commercial Officer.
July 1, 2024
·
2 min read
Business
Benitec Biopharma Announces Appointment of Kishen Mehta to its Board of Directors
Benitec Biopharma Inc. today announces the appointment of Kishen Mehta to the board of directors (BOD) of the Company, effective June 26, 2024.
July 1, 2024
·
5 min read
Press Releases
Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024
Avid Bioservices, Inc. today announced that it will report financial results for the quarter and fiscal year ended April 30, 2024, on July 2, 2024, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).
July 1, 2024
·
1 min read
Press Releases
Skye Bioscience Added to Russell 2000® and Russell 3000® Indexes
Skye Bioscience, Inc. today announced the Company has been included in the Russell 2000 ® Index and the broad-market Russell 3000 ® Index, effective at the U.S. market open on July 1, 2024.
July 1, 2024
·
5 min read
Press Releases
Q32 Bio Joins Russell 3000® Index
Q32 Bio Inc. today announced that the company is joining the broad-market Russell 3000 ® Index at the conclusion of the 2024 Russell Indexes annual reconstitution, effective upon the U.S. market opening today, July 1, 2024.
July 1, 2024
·
6 min read
Business
Avanos Medical, Inc. Appoints Indrani Franchini to Board of Directors
Avanos Medical, Inc. (NYSE: AVNS) today announced that Indrani Franchini has been appointed as a new independent member of the Avanos board of directors.
July 1, 2024
·
2 min read
Business
Labcorp to Announce Second Quarter Financial Results on August 1, 2024
Labcorp will release its financial results for the second quarter of 2024 before the market opens on Thursday, August 1, 2024.
July 1, 2024
·
1 min read
Previous
4 of 14
Next